Hyperphosphatemia in Dialysis: Strategies for Maintaining Target Serum Phosphate Levels

BTK Inhibitor Paradigm Shift in Waldenström Macroglobulinemia: Clinical Implications

Latest Data on JAK Inhibitors Prove Promising in Ankylosing Spondylitis

Gene Replacement Therapy for SMA is Effective in Both Pre-symptomatic Infants and Older Symptomatic Children

MONALEESA-2: Overall Survival Benefit Demonstrated in HR+ Advanced Breast Cancer with CDK 4/6 Inhibitor

Optimizing HFrEF Survival by Early Initiation of All Guideline-Directed Medical Therapies

For Preventing Events after TAVI in Patients with Atrial Fibrillation, NOAC Is a Viable Option

STR1VE-EU: Gene Replacement Therapy in Symptomatic Spinal Muscular Atrophy Is Associated with Substantial Benefit

Gene Therapy for Spinal Muscular Atrophy Effective as First- or Second-line Therapy

SELECT-PsA 1 and SELECT-PsA 2 Extended Trial Results Show Persistent Efficacy in Psoriatic Arthritis

Efficacy of Spinal Muscular Atrophy Therapies Depends on Early Initiation

ETNA-AF Registry: All Atrial Fibrillation Subgroups, Even the Old and Frail, Are Included in NOAC Benefit